CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection.

Liu Z, Gao X, Kan C, Li L, Zhang Y, Gao Y, Zhang S, Zhou L, Zhao H, Li M, Zhang Z, Sun Y
MedComm (2020). 2023 Jan 31;4(1):e208. doi: 10.1002/mco2.208. eCollection 2023 Feb. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.